Hypotonic intrapleural cisplatin chemotherapy as treatment for pleural carcinomatosis in an experimental model

Anticancer Research

Volumn 17, Issue 6 D, 1997, Pages 4547-4552

  Katano, Kuniyuki ^a   Tsujitani, Shunichi ^a   Saito, Hiroaki ^a   Ikeguchi, Masahide ^a   Maeta, Michio ^a   Kaibara, Nobuaki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Cisplatin; Fluid osmolarity; Intrapleural chemotherapy; Pleural carcinomatosis

Indexed keywords

CISPLATIN; HYPOTONIC SOLUTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CARCINOMATOSIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG UPTAKE; INTRAPLEURAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; OSMOLARITY; PLEURA CANCER; PRIORITY JOURNAL; RAT; SURVIVAL; TUMOR MODEL;

ANIMALS; BIOLOGICAL TRANSPORT; CARCINOMA, EHRLICH TUMOR; CISPLATIN; HYPOTONIC SOLUTIONS; INFUSIONS, PARENTERAL; MALE; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED STRAINS; PLEURA; PLEURAL NEOPLASMS; RATS; RATS, INBRED STRAINS;

EID: 0031408962     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Colleoni M, Sartori F, Calabro F, Nelli P, Vicario G, Sgarbossa G, Gaion F, Bortolotti L and Toniolo L: Surgery followed by intracavitary plus systemic chemotherapy in malignant pleural mesothelioma. Tumori 82: 53-56, 1996.
2. Ruckdeschel JC: Management of malignant pleural effusion: an overview. Semin Oncol 15, Suppl 3: 24-28, 1988.
3. Tsujitani S, Okuyama T, Watanabe A, Abe Y, Maehara Y and Sugimachi K: Intraperitoneal cisplatin during surgery for gastric cancer and peritoneal seeding. Anticancer Res 13: 1831-1834, 1993.
4. Kondo A, Maeta M, Oka A, Tsujitani S, Ikeguchi M and Kaibara N: Hypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice. Br J Cancer 73: 1166-1170, 1996.
5. LeRoy AF, Wehling ML, Sponseller H L, Friauf WS, Solomon RE, Dedrick RL, Litterst CL, Gram TE, Guarino AM and Becker DA: Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry. Biochem Med 18: 184-191, 1977.
6. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
7. Gibaldi M and Perrier D: Pharmacokinetics, 2nd ed. New York: Dekker, 1982.
8. Rusch VW, Figlin R, Godwin D and Piantadosi S: Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial. J Clin Oncol 9: 313-319, 1991.
9. Bogliolo GV, Lerza R, Bottino GB, Mencoboni, MP, Pannacciulli IM, Vannozzi M, Fulco RA, Merlo F and Esposito M: Regional pharmacokinetic selectivity of intrapleural cisplatin. Eur J Cancer 27: 839-842, 1991.
10. Los G and McVie JG: Experimental and clinical status of intraperitoneal chemotherapy. Eur J Cancer 26: 755-762, 1990.
11. Smith E and Brock AP: The effect of reduced osmolarity on platinum drug toxicity. Br J Cancer 59: 873-875, 1989.
12. Stephen RL, Novak JM, Jensen EM, Kablitz C and Buys SS: Effect of osmotic pressure on uptake of chemotherapeutic agents by carcinoma cells. Cancer Res 50: 4704-4708, 1990.
13. Novak JM, Cala PM, Ward DM, Buys SS and Kaplan J: Regulatory volume decrease in alveolar macrophages; cation loss is not correlated with changes in membrane recycling. J Cell Physiol 37: 243-250, 1988.
14. Gottlieb JA and Drewinko B: Review of the current clinical status of platinum co-ordination complexes in cancer chemotherapy. Cancer Chemother Rep 59: 621, 1975.
15. Rosenberg B: Anticancer activity of cis-dichlorodiammi-neplatinum(II) and some relevant chemistry. Cancer Treat Rep 63: 1433-1438, 1979.
16. Connors TA, Cleare MJ and Harrap KR. Structure-activity relationships of the antitumor platinum coordination complexes. Cancer Treat Rep 63: 1499-1502, 1979.
17. Groos E and Masters JR: Intravesical chemotherapy: studies on the relationship between osmolality and cytotoxicity. J Urol 136: 399-402, 1986.
18. Oleinick NL, Chiu S, Ramakrishman N and Xue L: The formation, identification, and significance of DNA-protein cross-links in mammalian cells. Br J Cancer 55, Suppl 8: 135, 1987.
19. Ohshima K: Effects of various osmotic solutions on membrane properties of smooth muscle cells of the guinea pig ureter. Invest Urol 19: 79-84, 1981.
20. Finkenzeller G, Newsome W, Lang F and Haussinger D: Increase of c-jun mRNA upon hypo-osmotic cell swelling of rat hepatoma cells. FEBS Lett 340: 163-166, 1994.
21. Campbell AB, Kalman SM and Jacobs C: Plasma platinum levels: relationship to cisplatin dose and nephrotoxicity. Cancer Treat Rep 67: 169-72, 1983.
22. Lindnér P, Heath D, Howell S, Naredi P and Hafstrómé L: Vasopressin modulation of peritoneal, lymphatic, and plasma drug exposure following intraperitoneal administration. Clin Cancer Res 2: 311-317, 1996.
23. Goel R, Cleary SM, Horton C, Kirmani S, Abramson I, Kelly C and Howell SB: Effect of sodium thiosulfate on the pharmacokinetics and toxicity of cisplatin. J Natl Cancer Inst 81: 1552-60, 1989.
24. Sugarbaker PH: Management of peritoneal carcinomatosis. Acta Med Austriaca 16: 57-60, 1989.
25. Myers CE and Collins JM: Pharmacology of intraperitoneal chemotherapy. Cancer Invest 1: 395-407, 1983.
26. Los G, Mutsaers PHA, van der Vijgh WJF, Baldew GS, de Graaf PW and McVie JG: Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy. Cancer Res 49: 3380-3384, 1989.
27. Moore AS, Kirk AC and Cardona AA: Intracavitary cisplatin chemotherapy experience with six dogs. J Vet Intern Med 5: 227-231, 1991.
28. Ichinose Y, Kara N, Ohta M, Asoh H, Yano T, Maeda K and Yagawa K: Hypotonic cisplatin treatment for carcinomatous pleuritis found at thoracotomy in patients with lung cancer. In vitro experiments and preliminary clinical results. J Thorac Cardiovasc Surg 105: 1041-1046, 1993.
29. Desoize B, Marechal F, Millart H and Cattan A: Correlation of clinical pharmacokinetic parameters of cisplatin with efficacy and toxicity. Biomed Pharmacother 45: 203-207, 1991.
30. Lerza R, Esposito M, Vannozzi M, Bottino GB, Bogliolo G and Pannacciulli I: High doses of intrapleural cisplatin in a case of malignant pleural mesothelioma. Clinical observations and pharmacokinetic analyses. Cancer 73: 79-84, 1994.